Astrocytoma, Grade III Clinical Trials

15 clinical trials for Astrocytoma, Grade III across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma — RECRUITING · PHASE1
Study of Olutasidenib and Temozolomide in HGG — RECRUITING · PHASE2
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM — RECRUITING · PHASE1
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) — RECRUITING
A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma — ACTIVE_NOT_RECRUITING · PHASE1
Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma — COMPLETED · NA
Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma. — COMPLETED · PHASE1
Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 — COMPLETED · PHASE1
Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine — TERMINATED · PHASE1
Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes — COMPLETED
Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma — COMPLETED · PHASE1
Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas — WITHDRAWN · NA
Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma — COMPLETED · PHASE1
Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors — COMPLETED · PHASE1
FORWARD Optune and Adjuvant TMZ in Grade II/III Astrocytoma — TERMINATED · PHASE2

Refine this search